RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells

References

• BertrandNWuJXuXKamalyNFarokhzadOCCancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biologyAdv Drug Deliv Rev20146622524270007
   PubMed Web of Science ®Google Scholar
• WangSZhaoJYangHBottom-up synthesis of WS2 nanosheets with synchronous surface modification for imaging guided tumor regressionActa Biomater20175844245428611005
   PubMed Web of Science ®Google Scholar
• TikekarRVNitinNDistribution of encapsulated materials in colloidal particles and its impact on oxidative stability of encapsulated materialsLangmuir201228259233924322616688
   PubMed Web of Science ®Google Scholar
• MüllerRHPetersenRDHommossAPardeikeJNanostructured lipid carriers (NLC) in cosmetic dermal productsAdv Drug Deliv Rev200759652253017602783
   PubMed Web of Science ®Google Scholar
• ÜnerMPreparation, characterization and physicochemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systemsPharmazie200661537538616724531
   PubMed Web of Science ®Google Scholar
• MüllerRHRadtkeMWissingSANanostructured lipid matrices for improved microencapsulation of drugsInt J Pharm20022421–212112812176234
   PubMed Web of Science ®Google Scholar
• LiuYMiyoshiHNakamuraMNanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticlesInt J Cancer2007120122527253717390371
   PubMed Web of Science ®Google Scholar
• ParveenSMisraRSahooSKNanoparticles: a boon to drug delivery, therapeutics, diagnostics and imagingNanomedicine20128214716621703993
   PubMed Web of Science ®Google Scholar
• KimCHLeeSGKangMJLeeSChoiYWSurface modification of lipid-based nanocarriers for cancer cell-specific drug targetingJ Pharm Invest2017473203227
   Google Scholar
• BuggeTHAntalisTMWuQType II transmembrane serine proteasesJ Biol Chem200928435231772318119487698
   PubMed Web of Science ®Google Scholar
• KellyKASetlurSRRossRDetection of early prostate cancer using a hepsin-targeted imaging agentCancer Res20086872286229118381435
   PubMed Web of Science ®Google Scholar
• KangMHParkMJYooHJRIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cellsEur J Pharm Biopharm201487348949924704199
   PubMed Web of Science ®Google Scholar
• VivèsESchmidtJPèlegrinACell-penetrating and cell-targeting peptides in drug deliveryBiochim Biophys Acta20081786212613818440319
   PubMed Web of Science ®Google Scholar
• LiuRLiXXiaoWLamKSTumor-targeting peptides from combinatorial librariesAdv Drug Deliv Rev2017110–1111337
   PubMed Web of Science ®Google Scholar
• SakuraiYKajimotoKHarashimaHAnti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculatureBiomater Sci2015391253126526261854
   PubMed Web of Science ®Google Scholar
• LiuYRanRChenJPaclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targetingBiomaterial2014351748354847
   PubMed Web of Science ®Google Scholar
• YoonHYKwakSSJangMHDocetaxel-loaded RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes: drug release, cytotoxicity, and antitumor efficacyInt J Pharm2017523122923728341149
   PubMedGoogle Scholar
• SadzukaYNakadeAHiramaREffects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposomeInt J Pharm2002238117118011996821
   PubMedGoogle Scholar
• MoserMBehnkeTHamers-AllinCKlein-HartwigKFalkenhagenJResch-GengerUQuantification of PEG-maleimide ligands and coupling efficiencies on nanoparticles with Ellman’s reagentAnal Chem201587189376938326284998
   PubMed Web of Science ®Google Scholar
• ZhangBZhangYYuDLung cancer gene therapy: transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene deliveryOncol Rep201737293794427959442
   PubMed Web of Science ®Google Scholar
• ShaoZShaoJTanBTargeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNAInt J Nanomedicine2015101223123325709444
   PubMed Web of Science ®Google Scholar
• ZhengDLiDLuXFengZEnhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral deliveryOncol Rep201023371772420127011
   PubMed Web of Science ®Google Scholar
• WuCZhaoJHuFDesign of injectable agar-based composite hydrogel for multi-mode tumor therapyCarbohydr Polym201818011212129103486
   PubMed Web of Science ®Google Scholar
• TomaykoMMReynoldsCPDetermination of subcutaneous tumor size in athymic (nude) miceCancer Chemother Pharmacol19892431481542544306
   PubMed Web of Science ®Google Scholar
• YangXYLiYXLiMZhangLFengLXZhangNHyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancerCaner Lett20133342338345
   PubMed Web of Science ®Google Scholar
• LiuDLiuFLiuZWangLZhangNTumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibodyMol Pharm2011862291230121923159
   PubMed Web of Science ®Google Scholar
• NeedhamDStoichevaNZhelevDVExchange of monooleoylphos-phatidylcholine as monomer and micelle with membranes containing poly(ethylene glycol)-lipidBiophys J1997735261526299370456
   PubMed Web of Science ®Google Scholar
• HuFQJiangSPDuYZYuanHYeYQZengSPreparation and characteristics of monostearin nanostructured lipid carriersInt J Pharm20063141838916563671
   PubMed Web of Science ®Google Scholar
• NaguibYWRodriguezBLLiXHurstingSDWilliamsROIIICuiZSolid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluationMol Pharm20141141239124924621456
   PubMed Web of Science ®Google Scholar
• FangGTangBChaoYZhangYXuHTangXImproved oral bioavailability of docetaxel by nanostructured lipid carriers: in vitro characteristics, in vivo evaluation and intestinal transport studiesRSC Adv201551179643796447
   Web of Science ®Google Scholar
• ErnstingMJMurakamiMRoyALiSDFactors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticlesJ Control Release2013172378279424075927
   PubMed Web of Science ®Google Scholar
• MatsumuraYMaedaHA new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancsCancer Res19864612 Pt 1638763922946403
   PubMed Web of Science ®Google Scholar
• DecuzziPGodinBTanakaTSize and shape effects in the biodistribution of intravascularly injected particlesJ Control Release2010141332032719874859
   PubMed Web of Science ®Google Scholar
• WickiAWitzigmannDBalasubramanianVHuwylerJNanomedicine in cancer therapy: challenges, opportunities, and clinical applicationsJ Control Release201520013815725545217
   PubMed Web of Science ®Google Scholar
• VermaAStellacciFEffect of surface properties on nanoparticle–cell interactionsSmall201061122119844908
   PubMed Web of Science ®Google Scholar
• NevesARLúcioMMartinsSLimaJLCReisSNovel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailabilityInt J Nanomedicine2013817718723326193
   PubMed Web of Science ®Google Scholar
• ZhaoLWeiYLiWSolid dispersion and effervescent techniques used to prepare docetaxel liposomes for lung-targeted delivery system: in vitro and in vivo evaluationJ Drug Target201119317117820429774
   PubMed Web of Science ®Google Scholar
• HillaireauHCouvreurPNanocarriers’ entry into the cell: relevance to drug deliveryCell Mol Life Sci200966172873289619499185
   PubMed Web of Science ®Google Scholar
• TeeranachaideekulVSoutoEBJunyaprasertVBMüllerRHCetyl palmitate-based NLC for topical delivery of Coenzyme Q 10 – development, physicochemical characterization and in vitro release studiesEur J Pharm Biopharm200767114114817346953
   PubMed Web of Science ®Google Scholar
• PawarAAChenDRVenkataramanCInfluence of precursor solvent properties on matrix crystallinity and drug release rates from nanoparticle aerosol lipid matricesInt J Pharm2012430122823722469694
   PubMedGoogle Scholar
• SonGHLeeBJChoCWMechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticlesJ Pharm Invest2017474287296
   Google Scholar
• KaurPGargTRathGMurthyRRGoyalAKDevelopment, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken designDrug Deliv20162361912192525544602
   PubMed Web of Science ®Google Scholar
• SouzaLGSilvaEJMartinsALDevelopment of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged releaseEur J Pharm Biopharm201179118919621352915
   PubMed Web of Science ®Google Scholar
• SelvamuthukumarSVelmuruganRNanostructured lipid carriers: a potential drug carrier for cancer chemotherapyLipids Health Dis201211115916623167765
   PubMedGoogle Scholar
• ZhangXGanYGanLNieSPanWPEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancerJ Pharm Pharmacol20086081077108718644200
   PubMed Web of Science ®Google Scholar
• MelikovKChernomordikLVArginine-rich cell penetrating peptides: from endosomal uptake to nuclear deliveryCell Mol Life Sci200562232739274916231085
   PubMed Web of Science ®Google Scholar
• BashyalSNohGKeumTChoiYWLeeSCell penetrating peptides as an innovative approach for drug delivery; then, present and the futureJ Pharm Invest2016463205220
   Google Scholar
• LiuYMeiLYuQMultifunctional tandem peptide modified paclitaxel-loaded liposomes for the treatment of vasculogenic mimicry and cancer stem cells in malignant gliomaACS Appl Mater Interfaces2015730167921680126173814
   PubMed Web of Science ®Google Scholar
• YamamotoYYoshidaMSatoMFeasibility of tailored, selective and effective anticancer chemotherapy by direct injection of docetaxel-loaded immunoliposomes into Her2/neu positive gastric tumor xenograftsInt J Oncol2011381333921109923
   PubMed Web of Science ®Google Scholar
• KedmiRBen-ArieNPeerDThe systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activationBiomaterial2010312668676875
   PubMed Web of Science ®Google Scholar
• MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release200065127128410699287
   PubMed Web of Science ®Google Scholar
• LiXXuHDaiXZhuZLiuBLuXEnhanced in vitro and in vivo therapeutic efficacy of codrug-loaded nanoparticles against liver cancerInt J Nanomedicine201275183519023055730
   PubMed Web of Science ®Google Scholar
• BaoAPhillipsWTGoinsBPotential use of drug carried-liposomes for cancer therapy via direct intratumoral injectionInt J Pharm2006316116216916580161
   PubMedGoogle Scholar
• NomuraTKoreedaNYamashitaFTakakuraYHashidaMEffect of particle size and charge on the disposition of lipid carriers after intra-tumoral injection into tissue-isolated tumorsPharm Res19981511281329487559
   PubMed Web of Science ®Google Scholar